Novel condensed heterocyclic compounds and their use

The general formula (I) [Formula 1] Wherein fused ring AB is 8-10 membered fused heterocyclic ring; However, when n is 2 or more, each R Compounds represented by, the salt or solvate thereof or a prodrug thereof, the present invention compounds kinase inhibitory action, particularly having the c-Jun N-terminal kinase inhibitory action, and metabolic diseases such as diabetes, for example, it is useful as a preventive and / or therapeutic agent for inflammatory diseases such as rheumatoid arthritis.